Radiofrequency Ablation Devices Market Scope And Analysis

Report Code : TIPRE00004752
Category : Life Sciences

No. of Pages : 150

Buy Now

Radiofrequency Ablation Devices Market Scope, Analysis, and Trends by 2031

Buy Now

Radiofrequency Ablation Devices Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 3.93 Billion
Market Size by 2031	US$ 12.08 Billion
Global CAGR (2023 - 2031)	12.2%
Historical Data	2021-2022
Forecast period	2023-2031
Segments Covered	By Product Devices Disposables By Application Surgical Oncology Cardiology Gynecology Cosmetology Pain Management
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Avanos Medical Inc Stryker Abbott Medtronic Boston Scientific Bard BD Angiodynamic Hologic Articure Merit medical

Radiofrequency Ablation Devices Market News and Recent Developments

The radiofrequency ablation devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for radiofrequency ablation devices market:

AtriCure, Inc., a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, announced that it has launched the EnCompass Clamp, a part of the Isolator Synergy Ablation System in the United States. The EnCompass Clamp received FDA 510(k) clearance for ablation of cardiac tissue during cardiac surgery and is designed to make concomitant surgical ablations more efficient. (Source: ATRICURE, INC., Press Release, 2022)
BD (Becton, Dickinson, and Company), a leading global medical technology company, announced today it has acquired Venclose, Inc., a provider of solutions for the treatment of chronic venous insufficiency (CVI) — a disease that is the result of malfunctioning valves and can lead to varicose veins. (Source: BD, Press Release, 2021)

Radiofrequency Ablation Devices Market Report Coverage and Deliverables

The “Radiofrequency Ablation Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles